The transplant-based medicine developer, backed by Alphabet, Partners Healthcare and Access Industries, floated in the middle of its range.

The local services platform, which counts Tencent as its largest investor, has filed for an offering that could net more than $4bn at a $60bn valuation.

The UCL spinout has priced its shares at the top of its range and secured $150m in proceeds, up from its initial target of $100m.

The Northwestern University-backed neurologic disorder therapy developer floated at the top of its range, increasing the share volume at the same time.

The Nan Fung-backed neurologic disorder therapy developer floated at the top of its range, increasing the share volume at the same time.

EMS-backed gene therapy developer AvroBio has secured $99.7m in an initial public offering that could potentially rise to $115m.

Qualcomm, China Mobile and SF Express are among seven cornerstone investors that will buy 10% of the shares in the Hong Kong offering.

The Salesforce and WPP-backed business data platform has set the range for an offering that would raise $202m at the top of its range.

The Alphabet and Salesforce-backed online survey platform, valued at $2bn as of 2014, has revealed it has confidentially filed to go public.